Universe Pharmaceuticals (UPC) Equity Average (2021 - 2024)
Historic Equity Average for Universe Pharmaceuticals (UPC) over the last 5 years, with Q3 2025 value amounting to $50816.2 billion.
- Universe Pharmaceuticals' Equity Average rose 12335.35% to $50816.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50816.2 billion, marking a year-over-year increase of 12335.35%. This contributed to the annual value of $50816.2 billion for FY2025, which is 12321.64% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Equity Average stood at $50816.2 billion for Q3 2025, which was up 12335.35% from $22751.5 billion recorded in Q3 2024.
- Universe Pharmaceuticals' Equity Average's 5-year high stood at $50816.2 billion during Q3 2025, with a 5-year trough of $33.9 million in Q3 2021.
- Over the past 5 years, Universe Pharmaceuticals' median Equity Average value was $15.8 billion (recorded in 2023), while the average stood at $9203.9 billion.
- Examining YoY changes over the last 5 years, Universe Pharmaceuticals' Equity Average showed a top increase of 16231037.06% in 2024 and a maximum decrease of 2086.28% in 2024.
- Over the past 5 years, Universe Pharmaceuticals' Equity Average (Quarter) stood at $33.9 million in 2021, then skyrocketed by 52103.81% to $17.7 billion in 2022, then decreased by 20.84% to $14.0 billion in 2023, then skyrocketed by 162310.37% to $22751.5 billion in 2024, then surged by 123.35% to $50816.2 billion in 2025.
- Its Equity Average stands at $50816.2 billion for Q3 2025, versus $22751.5 billion for Q3 2024 and $14.0 billion for Q1 2024.